BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 17465213)

  • 1. CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expression.
    Sato K; Kitajima Y; Kohya N; Koga Y; Ohtaka K; Miyazaki K
    Anticancer Res; 2007; 27(2):865-72. PubMed ID: 17465213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mismatch repair system decreases cell survival by stabilizing the tetraploid G1 arrest in response to SN-38.
    Bhonde MR; Hanski ML; Stehr J; Jebautzke B; Peiró-Jordán R; Fechner H; Yokoyama KK; Lin WC; Zeitz M; Hanski C
    Int J Cancer; 2010 Jun; 126(12):2813-25. PubMed ID: 19739070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of o6-methylguanine-DNA methyltransferase (MGMT) and mismatch repair gene (hMLH1) status on the sensitivity to alkylating agent 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea(ACNU) in gallbladder carcinoma cells.
    Sato K; Kitajima Y; Koga Y; Miyazaki K
    Anticancer Res; 2005; 25(6B):4021-8. PubMed ID: 16309194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular effects of CPT-11 on colon carcinoma cells: dependence on p53 and hMLH1 status.
    Magrini R; Bhonde MR; Hanski ML; Notter M; Scherübl H; Boland CR; Zeitz M; Hanski C
    Int J Cancer; 2002 Sep; 101(1):23-31. PubMed ID: 12209584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microsatellite instability due to hMLH1 deficiency is associated with increased cytotoxicity to irinotecan in human colorectal cancer cell lines.
    Vilar E; Scaltriti M; Balmaña J; Saura C; Guzman M; Arribas J; Baselga J; Tabernero J
    Br J Cancer; 2008 Nov; 99(10):1607-12. PubMed ID: 18941461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of chk1 at serine-345 affected by topoisomerase I poison SN-38.
    Hapke G; Yin MB; Wu J; Frank C; Rustum YM
    Int J Oncol; 2002 Nov; 21(5):1059-66. PubMed ID: 12370755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deficient MGMT and proficient hMLH1 expression renders gallbladder carcinoma cells sensitive to alkylating agents through G2-M cell cycle arrest.
    Sato K; Kitajima Y; Kohya N; Miyoshi A; Koga Y; Miyazaki K
    Int J Oncol; 2005 Jun; 26(6):1653-61. PubMed ID: 15870882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines.
    Arnold CN; Goel A; Boland CR
    Int J Cancer; 2003 Aug; 106(1):66-73. PubMed ID: 12794758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hMLH1 methylation, mismatch repair deficiency and microsatellite instability on chemoresistance of testicular germ-cell tumors.
    Olasz J; Mándoky L; Géczi L; Bodrogi I; Csuka O; Bak M
    Anticancer Res; 2005; 25(6B):4319-24. PubMed ID: 16309235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular conversion of irinotecan to its active form, SN-38, by native carboxylesterase in human non-small cell lung cancer.
    Ohtsuka K; Inoue S; Kameyama M; Kanetoshi A; Fujimoto T; Takaoka K; Araya Y; Shida A
    Lung Cancer; 2003 Aug; 41(2):187-98. PubMed ID: 12871782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Methylation of mismatch repair gene (MMR) in primary hepatocellular carcinoma].
    Zhang CJ; Li HM; Yau LM; Suen KW; Zhou GY; Yu F; Liew CT
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):433-6. PubMed ID: 15498213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA mismatch repair (MMR) mediates 6-thioguanine genotoxicity by introducing single-strand breaks to signal a G2-M arrest in MMR-proficient RKO cells.
    Yan T; Berry SE; Desai AB; Kinsella TJ
    Clin Cancer Res; 2003 Jun; 9(6):2327-34. PubMed ID: 12796402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between mismatch repair gene and irinotecan-based chemotherapy in metastatic colon cancer.
    Ma J; Zhang Y; Shen H; Kapesa L; Liu W; Zeng M; Zeng S
    Tumour Biol; 2015 Dec; 36(12):9599-609. PubMed ID: 26142736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter methylation of the hMLH1 gene and protein expression of human mutL homolog 1 and human mutS homolog 2 in resected esophageal squamous cell carcinoma.
    Tzao C; Hsu HS; Sun GH; Lai HL; Wang YC; Tung HJ; Yu CP; Cheng YL; Lee SC
    J Thorac Cardiovasc Surg; 2005 Nov; 130(5):1371. PubMed ID: 16256791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hMLH1 in sterigmatocystin-induced G₂ phase arrest in human esophageal epithelial Het-1A cells in vitro.
    Wang J; Huang S; Xing L; Shen H; Yan X; Wang J; Zhang X
    Toxicol Lett; 2013 Mar; 217(3):226-34. PubMed ID: 23296099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
    Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
    Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen up-regulates mismatch repair activity in normal and malignant endometrial glandular cells.
    Miyamoto T; Shiozawa T; Kashima H; Feng YZ; Suzuki A; Kurai M; Nikaido T; Konishi I
    Endocrinology; 2006 Oct; 147(10):4863-70. PubMed ID: 16825317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.
    Fang JY; Lu R; Mikovits JA; Cheng ZH; Zhu HY; Chen YX
    Cancer Lett; 2006 Feb; 233(1):124-30. PubMed ID: 16473673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsatellite instability is a predictive factor of the tumor response to irinotecan in patients with advanced colorectal cancer.
    Fallik D; Borrini F; Boige V; Viguier J; Jacob S; Miquel C; Sabourin JC; Ducreux M; Praz F
    Cancer Res; 2003 Sep; 63(18):5738-44. PubMed ID: 14522894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.